![](/img/cover-not-exists.png)
Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma
Anderson, D. R., Grillo-López, A., Varns, C., Chambers, K. S., Hanna, N.Volume:
25
Language:
english
Journal:
Biochemical Society Transactions
DOI:
10.1042/bst0250705
Date:
May, 1997
File:
PDF, 355 KB
english, 1997